Company / Capital Expenditures
AVADEL PHARMACEUTICALS PLC Capital Expenditures History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
-
FY2024
5-year range
$0 / $716.0K
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#190 of 194
Health Care
What the data says
Declined from $716,000 to $0 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 194
▼
Key checks
Key Insights
- Peak capital expenditures was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0 | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $716.0K | +2653.8% |
| FY2021 | $26.0K | -73.5% |
| FY2020 | $98.0K | +237.9% |
| FY2019 | $29.0K | -83.7% |
| FY2018 | $178.0K | -69.9% |
| FY2017 | $591.0K | -50.8% |
| FY2016 | $1.2M | -26.3% |
| FY2015 | $1.6M | -5.7% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026